We concluded that the APOE3Ch variant was able to produce a protective pattern of early tau phosphorylation defined as low pTau S396 in cerebral organoids derived from an AD-protected and non-protected patient within the PSEN1 E280A background. This evidence concerns the gene MAPT and Alzheimer disease.